Home Other Building Blocks 66644-81-3
66644-81-3,MFCD00867658
Catalog No.:AA01CCMV

66644-81-3 | Veralipride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
min. 98.0 area%
in stock  
$459.00   $322.00
- +
25mg
min. 98.0 area%
in stock  
$1,866.00   $1,307.00
- +
100mg
min. 98.0 area%
in stock  
$4,088.00   $2,862.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01CCMV
Chemical Name:
Veralipride
CAS Number:
66644-81-3
Molecular Formula:
C17H25N3O5S
Molecular Weight:
383.4625
MDL Number:
MFCD00867658
SMILES:
C=CCN1CCCC1CNC(=O)c1cc(cc(c1OC)OC)S(=O)(=O)N
Properties
Computed Properties
 
Complexity:
592  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
1  
XLogP3:
0.8  

Literature

Title: [Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms].

Journal: Ginecologia y obstetricia de Mexico 20120701

Title: Preparation, spectroscopic and thermal characterization of new metal complexes of verlipride drug. In vitro biological activity studies.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120601

Title: Modelling the Double Peak Phenomenon in pharmacokinetics.

Journal: Computer methods and programs in biomedicine 20111101

Title: [Parkinsonism induced by sulpiride and veralipride: two different stories].

Journal: Medicina clinica 20111015

Title: Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.

Journal: Climacteric : the journal of the International Menopause Society 20100401

Title: Bioactivity of isoflavones: assessment through a theoretical model as a way to obtain a 'Theoretical Efficacy Related to Estradiol (TERE)'.

Journal: International journal of molecular sciences 20100101

Title: Actual status of veralipride use.

Journal: Clinical interventions in aging 20100101

Title: Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.

Journal: International journal of women's health 20100101

Title: Pharmacological causes of hyperprolactinemia.

Journal: Therapeutics and clinical risk management 20071001

Title: Reversible jump Markov chain Monte Carlo for deconvolution.

Journal: Journal of pharmacokinetics and pharmacodynamics 20070601

Title: Treatment of premature menopause in breast cancer patients.

Journal: Acta chirurgica Belgica 20070601

Title: Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review.

Journal: Climacteric : the journal of the International Menopause Society 20070201

Title: Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Journal: Drug safety 20070101

Title: Tardive blepharospasm beginning after withdrawal of veralipride.

Journal: Movement disorders : official journal of the Movement Disorder Society 20061101

Title: The safety of veralipride.

Journal: Expert opinion on drug safety 20060901

Title: Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.

Journal: Journal of endocrinological investigation 20060101

Title: [Clinical guide to the menopause and post-menopause].

Journal: Atencion primaria 20050930

Title: The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Journal: Pharmaceutical research 20050801

Title: [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].

Journal: La Revue de medecine interne 20050601

Title: Tardive dyskinesia after long-term veralipride treatment.

Journal: The Journal of neuropsychiatry and clinical neurosciences 20050101

Title: Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.

Journal: American journal of obstetrics and gynecology 20041201

Title: [Post-menopausal hot flushes and parkinsonism].

Journal: Revista de neurologia 20041101

Title: Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040401

Title: Alternatives to estrogen.

Journal: The Medical clinics of North America 20030901

Title: Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.

Journal: Maturitas 20030314

Title: [Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database].

Journal: Therapie 20030101

Title: The Women's Health Questionnaire (WHQ): Frequently Asked Questions (FAQ).

Journal: Health and quality of life outcomes 20030101

Title: Modification of vasomotor symptoms after various treatment modalities in the postmenopause.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20010501

Title: Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.

Journal: Arquivos de neuro-psiquiatria 20010301

Title: Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs.

Journal: Clinical immunology (Orlando, Fla.) 19990301

Title: [Parkinson syndrome induced by veralipride].

Journal: Minerva ginecologica 19950601

Title: [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].

Journal: Therapie 19950101

Title: Veralipride-induced tardive dystonia in a patient with bipolar psychosis.

Journal: Italian journal of neurological sciences 19921001

Title: Melis GB, et al. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. Obstet Gynecol. 1988 Nov;72(5):688-92.

Title: Carranza-Lira S, et al. Actual status of veralipride use. Clin Interv Aging. 2010 Sep 7;5:271-6.

Title: Valencia MH, e al. Safety of veralipride for the treatment of vasomotor symptoms of menopause. Menopause. 2014 May;21(5):484-92.

Title: Franchignoni FP, et al. Parkinson syndrome induced by veralipride. Minerva Ginecol. 1995 Jun;47(6):277-9.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:66644-81-3 Molecular Formula|66644-81-3 MDL|66644-81-3 SMILES|66644-81-3 Veralipride